Ebronucimab (Anti-PCSK9)Ebronucimab (Anti-PCSK9)
Move your mouse over image or click to enlarge

Ebronucimab (Anti-PCSK9)

Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD.
Cat# Size Price Qty Buy
A2843-1mg*25 1mg*25
£4,152.00
A2843-1mg*5 1mg*5
£1,384.00
A2843-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2843

Related Documents